http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008534000-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-905
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-02
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K13-00
filingDate 2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008534000-A
titleOfInvention Adjuvant for embryo and / or cell manipulation medium
abstract Supplements for embryo and / or cell manipulation medium The medium used for embryo and cell manipulation contains the following compounds: synthetic hyaluronan (sHA), one of phospholipids or unsaturated fatty acids (PLFA) obtained from soybean seeds or The quality of the embryo and cell manipulation medium by replacing it with other compounds that are normally added to the embryo manipulation medium and thereby causing serious damage and / or contamination by viruses, prions, endotoxins, etc. And this is important for the production of transgenic animals and the quality of embryos and cells that it is desired to generate for the production of animals and for cell therapy or assisted reproduction Reducing adhesion and increasing viscosity without losing fluidity of the operating medium; this can be ICSI, nuclear transfer, embryo biopsy, pre-transplantation stage or cell It is important for micromanipulation, such as microinjection of fused cells into the embryo.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017214305-A
priorityDate 2005-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0970240-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9221234-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001017160-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003517276-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409298798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID36470
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3847
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3847
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID36470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712567
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1336
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291

Total number of triples: 40.